Nabla Bio
PrivateLast Round
Series C
Jun 17, 2025
Total Funding Raised
$107.38M
Company Overview
Nabla Bio is a biotechnology company that develops an AI-driven platform for the rational design of developable, selective, and functional antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nabla Bio Comparables
Compare Nabla Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 89% | |
| Evozyne | 85% | |
| EvolutionaryScale | 85% | |
Nabla Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2025 | ||||
| Series A | May 14, 2024 | ||||
| Seed | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 | ||||
| Accelerator | Aug 24, 2020 |
Nabla Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | Series C |
| DST Global | Series C |
| Khosla Ventures | Series A, Seed |
| Cantos Ventures | Seed |
| Zetta Venture Partners | Series A, Seed |
| Pillar VC | Series A, Seed |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Received coverage in Science Magazine and Endpoints News.
- Jan 1, 2026
Partnerships disclosed with AstraZeneca, Takeda, and Bristol Myers Squibb.
Nabla Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nabla Bio's valuation, stock price, and market status.